MONEY

Goldman Sachs reiterates Buy on 4D Molecular Therapeutics, highlights promising gene therapy results

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 19, 2024 - 20:00
Goldman Sachs reiterates Buy on 4D Molecular Therapeutics, highlights promising gene therapy results
Read More

Tags:

Previous Article

Workday shares see price target increase, with potential outperformance in FINS ...

Next Article

AppLovin stock remains a Buy as Citi raises target, citing confidence in softwar...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Morgan Stanley sees further upside for Viking Therapeutics shares, highlights VK2735 tolerability

Morgan Stanley sees further upside for Viking Therapeut...

Tomas Kauer - Mode... Sep 12, 2024

AXIS Capital names Sara Mitchell as Head of Global Markets

AXIS Capital names Sara Mitchell as Head of Global Markets

Tomas Kauer - Mode... Sep 17, 2024

Astellas Announces FDA Listing of DIGITIVA™ for the Management of Heart Failure

Astellas Announces FDA Listing of DIGITIVA™ for the Man...

Tomas Kauer - Mode... Sep 19, 2024